文献速递血液透析通路

自体动静脉瘘流出道狭窄一线腔内治疗的网状Meta分析

Network meta-analysis of trials comparing first line endovascular treatments for arteriovenous fistula stenosis.
PubMed 文献 · J Vasc Surg · 2020-12-29

结果显示药物涂层球囊6个月失败率显著低于普通球囊(OR 0.39,95%CI 0.18-0.81),但与切割球囊差异无统计学意义;1年时三种治疗无显著差异。

要点

  • 药物涂层球囊6个月疗效优于普通球囊,失败风险显著降低
  • 药物涂层球囊与切割球囊6个月疗效差异无统计学意义
  • 三种腔内治疗1年失败率无显著差异,长期疗效待研究

核心结论

  • 在自体动静脉瘘流出道狭窄患者中,药物涂层球囊6个月失败率显著优于普通球囊。
  • 药物涂层球囊的长期疗效尚需进一步研究。

研究设计与样本

  • 检索Medline(通过PubMed)和SCOPUS数据库,排除中心静脉狭窄研究。

主要发现

  • 药物涂层球囊6个月失败率显著低于普通球囊(OR 0.39,95%CI 0.18-0.81)。
  • 药物涂层球囊与切割球囊6个月失败率差异无统计学意义(OR 0.65,95%CI 0.20-2.12)。
  • 三种治疗1年失败率差异无统计学意义。

关键数值与推荐

  • 主要结局为治疗后6个月和1年的失败率。
  • 药物涂层球囊6个月对比普通球囊OR 0.39(95%CI 0.18-0.81)。
  • 药物涂层球囊6个月对比切割球囊OR 0.65(95%CI 0.20-2.12)。

临床怎么用

  • 对于自体动静脉瘘流出道狭窄,可优先考虑药物涂层球囊以降低6个月失败率。
  • 需权衡药物涂层球囊与切割球囊的疗效,两者6个月效果无显著差异。
  • 长期疗效不确定,应个体化选择并加强随访。

局限性

  • 1年随访数据未显示显著差异,长期疗效证据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated the comparative effectiveness of different endovascular treatments for patients with failing autogenous arteriovenous fistulas (AVFs) with outflow vein stenosis. METHODS: The Medline (via PubMed) and SCOPUS databases were searched. We performed a systematic review and network meta-analysis of randomized controlled trials that had investigated the effectiveness of plain balloon angioplasty (PBA), cutting balloon angioplasty, and drug-coated balloon angioplasty (DCBA) to treat vein stenoses in autogenous AVFs. Studies of central vein stenosis were excluded. The main outcome measures were the failure rates at 6 months and 1 year after treatment. RESULTS: Eleven randomized controlled trials were included, with 814 patients, 395 of whom had undergone PBA. The network meta-analysis showed that DCBA at 6 months was significantly more effective than PBA (odds ratio, 0.39; 95% confidence interval, 0.18-0.81) and ranked as the best treatment option, although the difference was not statistically significant compared with cutting balloon angioplasty (odds ratio, 0.65; 95% confidence interval, 0.20-2.12). The differences among the three treatments at 1 year were not statistically significant. Additional conventional pairwise meta-analyses did not find significant differences at 1 year. CONCLUSIONS: In failing AVFs with outflow stenosis, DCBA was significantly superior to PBA, with improved 6-month failure rates. However the effectiveness of DCBA in the long term deserves further investigation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tripsianis G, Christaina E, Argyriou C, et al. Network meta-analysis of trials comparing first line endovascular treatments for arteriovenous fistula stenosis. J Vasc Surg. 2020. PMID: 33385504. doi:10.1016/j.jvs.2020.12.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。